Bacon BR, Powell LW, Adams PC.
et al. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology.1999;116:193-207.
Cogswell ME, McDonnell SM, Khoury MJ.
et al. Iron overload, public health, and genetics. Ann Intern Med.1998;129:971-979.
Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med.1998;129:925-931.
Barton JC, McDonnell SM, Adams PC.
et al. and the Hemochromatosis Management Working Group. Management of hemochromatosis. Ann Intern Med.1998;129:932-939.
Feder JN, Gnirke A, Thomas W.
et al. A novel MHC class I-like gene is mutated in patients with hereditary
haemochromatosis. Nat Genet.1996;13:399-408.
Bennett MJ, Lebron JA, Bjorkman PJ. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature.2000;403:46-53.
Roy CN, Penny DM, Feder JN, Enns CA. The hereditary hemochromatosis protein, HFE,
specifically regulates transferrin-mediated iron uptake in HeLa cells. J Biol Chem.1999;274:9022-9028.
Feder JN, Penny DM, Irrinki A.
et al. The hemochromatosis gene product complexes with the transferrin receptor
and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A.1998;95:1472-1477.
Burke W, Thomson E, Khoury MJ.
et al. Hereditary hemochromatosis: gene discovery and its implications for
population-based screening. JAMA.1998;280:172-178.
Rivard SR, Mura C, Simard H.
et al. Mutational analysis in the HFE gene inpatients
with hereditary haemochromatosis in Saquenay-Lac-Saint-Jean (Quebec, Canada). Br J Haematol.2000;108:854-858.
Fabrega E, Castro B, Sanchez-Castro L.
et al. Prevalence of the HFE Cys282Tyr mutation of
the haemochromatosis gene (GH) in Cantabria. Med Clin (Barc).1999;112:451-453.
Nielsen P, Carpinteiro S, Fischer R.
et al. Prevlence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control
subjects in northern Germany. Br J Haematol.1998;103:842-845.
Sanchez M, Gruguera M, Bosch J.
et al. Prevalence of the Cys282Tyr and His63Asp HFE
gene mutations in Spanish patients with hemochromatosis and controls. J Hepatol.1998;29:725-728.
Bradley LA, Johnson DD, Palomaki GE.
et al. Hereditary haemochromatosis mutation frequencies in the general population. J Med Screen.1998;5:34-36.
Bacon BR, Olynyk JK, Brunt EM.
et al. HFE genotype in patients with hemochromatosis
and in patients with liver disease. Ann Intern Med.1999;130:953-962.
McDonnell SM, Hover A, Gloe D.
et al. Population-based screening for hemochromatosis using phenotypic and
DNA testing among employees of health maintenance organizations in Springfield,
Missouri. Am J Med.1999;107:30-37.
Mortimore M, Merryweather-Clarke AT, Robson KJ, Powell LW. The haemochromatosis gene: a global perspective and implications for
the Asia-Pacific region. J Gastroenterol Hepatol.1999;14:838-843.
Distante S, Berg JP, Lande K.
et al. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of
Oslo and its phenotypic expression. Scand J Gastroenterol.1999;34:529-534.
Beutler E, Gelbart T, West C.
et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis.1996;22:187-194.
Steinberg KK, Sanderlin KC, Ou CY.
et al. DNA banking in epidemiologic studies. Epidemiol Rev.1997;19:156-162.
National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination
Survey, 1988-94. Vital Health Stat.1994;32:1-407.
National Center for Health Statistics, Centers for Disease Control
and Prevention. Plan and operation of the Third National Health and Nutrition Examination
Survey (NHANES III, 1988-1994): reference manuals and reports. In: Weighting and Estimation Methodology Report. Hyattsville, Md: US Dept of Health and Human Services, Public Health
Service, Centers for Disease Control and Prevention; 1996.
Clayton EW, Steinberg KK, Khoury MJ.
et al. Informed consent for genetic research on stored tissue samples. JAMA.1995;274:1786-1792.
Livak KJ, Flood SJ, Marmaro J.
et al. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched
probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Applications.1995;4:357-362.
Not Available. TaqMan Probe Design, Synthesis, and Purification. Foster City, Calif: Perkin-Elmer (Applied Biosystems Division); 1995.
Livak K, Marmaro J, Todd J. Towards fully automated genome-wide polymorphism screening. Nat Genet.1995;9:341-342.
Lynas C. A cheaper and more rapid polymerase chain reaction-restriction fragment
length polymorphism method for the detection of the HLA-H gene mutations occurring in hereditary hemochromatosis. Blood.1997;90:4235-4236.
Weisberg S. Applied Linear Regression. 2nd ed. New York, NY: John Wiley & Sons; 1985.
National Center for Health Statistics. Analytic and Reporting Guidelines: The Third National
Health and Nutritional Examination Survey, NHANES III (1988-94). Hyattsville, Md: National Center for Health Statistics; 1996.
Olynyk JK, Cullen DJ, Aquilia S.
et al. A population-based study of the clinical expression of the hemochromatosis
gene. N Engl J Med.1999;341:718-724.
Burt MJ, George PM, Upton JD.
et al. The significance of haemochromatosis gene mutations in the general
Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes on measurements
of iron overload in patients attending a health appraisal clinic. Ann Intern Med.2000;133:329-337.
Marshall DS, Linfert DR, Tsongalis GJ. Prevalence of the C282Y and H63D polymorphisms in a multi-ethnic control
population. Int J Mol Med.1999;4:389-393.
Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet.1997;34:275-278.
Jeffrey S, Crosby A, Plange-Rhule J.
et al. Evidence from a Ghanaian population of known African descent to support
the proposition that hemochromatosis is a Caucasian disorder. Genet Test.1999;3:375-377.
Gangaidzo IT, Moyo VM, Saugweme T.
et al. Iron overload in urban Africans in the 1990s. Gut.1999;45:278-283.
Cullen LM, Gao X, Easteal S, Jazwinska EC. The hemochromatosis 845 G→A and 187 C→G mutations: prevalence
in non-Caucasian populations. Am J Hum Genet.1998;62:1403-1407.
Centers for Disease Control and Prevention. Iron overload disorders among Hispanics in San Diego, California, 1995. MMWR Morb Mortal Wkly Rep.1996;45:991-993.
Looker AC, Johnson CL. Prevalence of elevated serum transferrin saturation in adults in the
United States. Ann Intern Med.1998;129:940-945.
Edwards CA, Griffen LM, Goldgar D.
et al. Prevalence of hemochromatosis among 11,065 presumably healthy blood
donors. N Engl J Med.1988;318:1355-1362.